| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 11/13/2014 | US20140336356 Peptide agonists of glp-1 activity |
| 11/13/2014 | US20140336143 Treatment of ebv and khsv infection and associated abnormal cellular proliferation |
| 11/13/2014 | US20140336132 Romidepsin solid forms and uses thereof |
| 11/13/2014 | US20140336130 Targeting en2, pax2, and/or defb1 for treatment of prostate conditions |
| 11/13/2014 | US20140336129 Targeting the EGFR-SGLT1 Interaction for Cancer Therapy |
| 11/13/2014 | US20140336124 Compositions for Regenerating Defective or Absent Myocardium |
| 11/13/2014 | US20140336121 Factor h for treatment of rheumatoid arthritis |
| 11/13/2014 | US20140336120 Compositions And Method For Treatment Of Ischemic Neuronal Reperfusion Injury |
| 11/13/2014 | US20140336118 Polypeptide for the protection against heart ischemia-reperfusion injury |
| 11/13/2014 | US20140336114 Buffers for Controlling the pH of Bone Morphogenetic Proteins |
| 11/13/2014 | US20140336113 Compositions and methods for treating and preventing hyperlipidemia, fatty liver, atherosclerosis and other disorders associated with metabolic syndrome |
| 11/13/2014 | US20140336112 Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| 11/13/2014 | US20140336111 Therapeutic Use of Activators of Zinc Finger Protein GL13 |
| 11/13/2014 | US20140335607 Methods and compositions relating to restricted expression lentiviral vectors and their applications |
| 11/13/2014 | US20140335186 Methods and compositions for enhancing cd4+ regulatory t cells |
| 11/13/2014 | US20140335183 Wound healing profile |
| 11/13/2014 | US20140335169 Peptide Pharmaceutical for Oral Delivery |
| 11/13/2014 | US20140335168 Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| 11/13/2014 | US20140335162 Pharmaceutical composition for treatment of allergic reactions |
| 11/13/2014 | US20140335160 Biodegradable Nanoparticles as Novel Hemoglobin-Based Oxygen Carriers and Methods of Using the Same |
| 11/13/2014 | US20140335159 Biodegradable Nanoparticles as Novel Hemoglobin-Based Oxygen Carriers and Methods of Using the Same |
| 11/13/2014 | US20140335155 COMPOSITION FOR IMPROVING SKIN CONDITIONS, CONTAINING EXTRACELLULAR DOMAIN OF HUMAN BONE MORPHOGENETIC PROTEIN RECEPTOR 1a AS ACTIVE INGREDIENT |
| 11/13/2014 | US20140335152 Methods and compositions for enhancing the uptake of therapeutic agents by target cells |
| 11/13/2014 | US20140335146 Growth factor anchoring type bone graft material, method for producing growth factor anchoring type bone graft material, kit for producing growth factor anchoring type bone graft material, and method for forming bone |
| 11/13/2014 | US20140335145 Biomaterials and implants for enhanced cartilage formation, and methods for making and using them |
| 11/13/2014 | US20140335135 Pharmaceutical composition |
| 11/13/2014 | US20140335129 Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins |
| 11/13/2014 | US20140335127 System and method for the production of recombinant glycosylated proteins in a prokaryotic host |
| 11/13/2014 | US20140335124 Recombinant Trivalent Vaccine Against Human Influenza |
| 11/13/2014 | US20140335113 Factor h for transplantation |
| 11/13/2014 | US20140335111 Vaccines and immunotherapeutics using il-28 and compositions and methods of using the same |
| 11/13/2014 | US20140335108 Utility of insulin-like 6 (insl6) for the treatment of autoimmune diseases |
| 11/13/2014 | US20140335094 Mammalian cytokines; related reagents and methods |
| 11/13/2014 | US20140335086 Modified heat shock protein-antigenic peptide complex |
| 11/13/2014 | US20140335078 Use Of Complement Inhibitors To Treat Ocular Diseases |
| 11/13/2014 | US20140335074 Methods for improving medical therapies |
| 11/13/2014 | US20140335072 Method of Treating or Reducing EFP |
| 11/13/2014 | US20140335071 Composition Exhibiting a von Willebrand Factor (vWF) Protease Activity Comprising a Polypeptide Chain with the Amino Acid Sequence AAGGILHLELLV |
| 11/13/2014 | US20140335070 Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency |
| 11/13/2014 | US20140335068 Novel use of ec-sod for treating angiogenesis-mediated eye diseases |
| 11/13/2014 | US20140335067 Novel use of ec-sod and method for preparing thereof |
| 11/13/2014 | US20140335064 Human skin equivalents expressing exogenous polypeptides |
| 11/13/2014 | US20140335056 Sustained releasing pharmaceutical composition |
| 11/13/2014 | US20140335053 Novel mhc class ii restricted t cell epitopes from the cancer antigen, ny eso-1 |
| 11/13/2014 | US20140335052 Combination therapy for treating hcv infection in an hcv-hiv coinfected patient population |
| 11/13/2014 | US20140335050 Methods, compositions, and kits for the treatment of cancer |
| 11/13/2014 | US20140335045 bFGF-POLYMER CONJUGATES, METHODS FOR MAKING THE SAME AND APPLICATIONS THEREOF |
| 11/13/2014 | US20140335018 Pharmaceutical composition comprising modified hemoglobin-based therapeutic agent for cancer targeting treatment and diagnostic imaging |
| 11/11/2014 | US8884214 Methods of using halogenated peptides as internal standards for liquid chromatography-mass spectrometry |
| 11/11/2014 | US8883982 Compositions and methods for increasing serum half-life |
| 11/11/2014 | US8883971 CTLA4 proteins and their uses |
| 11/11/2014 | US8883967 Branched amphipathic oligo-peptides that self-assemble into vesicles |
| 11/11/2014 | US8883966 RAB6KIFL/KIF20A epitope peptide and vaccines containing the same |
| 11/11/2014 | US8883965 Compounds |
| 11/11/2014 | US8883964 Compositions comprising modified collagen and uses therefor |
| 11/11/2014 | US8883963 Peptidomimetics with glucagon antagonistic and GLP 1 agonistic activities |
| 11/11/2014 | US8883962 Zinc-responsive peptides, and methods of use thereof |
| 11/11/2014 | US8883862 Method for controlled release of parathyroid hormone from cross-linked hyaluronic acid hydrogel |
| 11/11/2014 | US8883823 Crystalline forms of a prolyl hydroxylase inhibitor |
| 11/11/2014 | US8883770 Synthetic bile acid compositions and methods |
| 11/11/2014 | US8883756 SDF-1 delivery for treating ischemic tissue |
| 11/11/2014 | US8883755 Mitochondrial targeted RNA expression system and use thereof |
| 11/11/2014 | US8883742 Peptide increasing fusiogenic capacity of a gamete |
| 11/11/2014 | US8883741 Stimulator of genital, sexual and reproductive function |
| 11/11/2014 | US8883740 Peptides, compositions, and uses thereof |
| 11/11/2014 | US8883739 Osteocalcin as a treatment for male reproductive disorders |
| 11/11/2014 | US8883738 Use of a peptide fragment of CD44v6 in the treatment of ophthalmic diseases |
| 11/11/2014 | US8883737 Methods of treating cancer |
| 11/11/2014 | US8883736 Compositions and methods for treating and diagnosing cancer |
| 11/11/2014 | US8883734 Proteasome-activating anti-aging peptides and compositions containing same |
| 11/11/2014 | US8883732 Therapeutic application of adiponectin in patients with ventricular fibrillation |
| 11/11/2014 | US8883731 Agent for reducing risk in onset of disease ascribable to non-dipper circadian rhythm of blood pressure |
| 11/11/2014 | US8883730 Human lung surfactant protein, SP-D, modulates eosinophil activation and survival and enhances phagocytosis of apoptotic bosinophils |
| 11/11/2014 | US8883728 Intranasal administration of active agents to the central nervous system |
| 11/11/2014 | US8883726 Fibroblast growth factor 21 variants |
| 11/11/2014 | US8883725 Compositions and methods for modulating skin pigmentation |
| 11/11/2014 | US8883724 Active antiangiogenic therapy |
| 11/11/2014 | US8883723 Conjugate of insulin and vitamin B12 for oral delivery |
| 11/11/2014 | US8883722 Human insulin containing additional disulfide bonds |
| 11/11/2014 | US8883721 Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof |
| 11/11/2014 | US8883720 Template-fixed beta-hairpin peptidomimetics with CXCR4 antagonizing activity |
| 11/11/2014 | US8883718 Treating cancer |
| 11/11/2014 | US8883717 Antigenic compositions and methods |
| 11/11/2014 | US8883716 Method for treating damaged tissue of the CNS |
| 11/11/2014 | US8883480 Antiviral peptide against avian influenza virus H9N2 |
| 11/11/2014 | US8883477 Oligoadenylate synthetase (OAS) |
| 11/11/2014 | US8883450 Signal peptide, and use thereof for producing recombinant proteins |
| 11/11/2014 | US8883449 Single-chain insulin |
| 11/11/2014 | US8883435 Inhibitors of Bruton's tyrosine kinase |
| 11/11/2014 | US8883413 Compstatin analogs with improved activity |
| 11/11/2014 | US8883206 Pharmaceutical composition and administrations thereof |
| 11/11/2014 | US8883184 Methods and compositions for regenerating connective tissue |
| 11/11/2014 | US8883174 Compositions for stimulation of mammalian innate immune resistance to pathogens |
| 11/11/2014 | US8883173 Synthetic antigenic peptides and lipopeptides derived from Mycobacterium avium subsp. paratuberculosis |
| 11/11/2014 | US8883165 Modified peptide vaccine derived from influenza M2 |
| 11/11/2014 | US8883155 Methods for treating hematopoietic malignancies |
| 11/11/2014 | US8883153 Methods for preventing and treating angioedema |
| 11/11/2014 | US8883148 Prevention of joint destruction |
| 11/11/2014 | US8883146 Protein formulations and methods of making same |
| 11/11/2014 | US8883145 Methods of treatment with DLL4 antagonists and an anti-hypertensive agent |